Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo

Food and Chemical Toxicology

Volumn 46, Issue 8, 2008, Pages 2680-2688

  Hseu, You Cheng ^a   Chen, Ssu Ching ^b   Chen, Huang Chi ^a   Liao, Jiuun Wang ^c   Yang, Hsin Ling ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL KAOHSIUNG NORMAL UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Antrodia Camphorata; Apoptosis; Breast cancer; Cell cycle arrest

Indexed keywords

ANTRODIA CAMPHORATA EXTRACT; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; CYCLINE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PLANT EXTRACT;

ANTINEOPLASTIC ACTIVITY; ANTRODIA CAMPHORATA; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER INHIBITION; CANCER PREVENTION; CANCER REGRESSION; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG EFFICACY; FERMENTATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MEDICINAL PLANT; NICK END LABELING; NUDE MOUSE; TISSUE SECTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; FEMALE; FERMENTATION; FLOW CYTOMETRY; GENES, BCL-2; HUMANS; IN SITU NICK-END LABELING; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; POLYPORALES; PROLIFERATING CELL NUCLEAR ANTIGEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS; TAIWANOFUNGUS CAMPHORATUS;

EID: 47149101600     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.04.036     Document Type: Article

References (44)

1. Adams J.M., and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281 (1998) 1322-1326
2. Bold R.J., Termuhlen P.M., and McConkey D.J. Apoptosis, cancer and cancer therapy. Surgical Oncology 6 (1997) 133-142
3. Carnero A. Targeting the cell cycle for cancer therapy. British Journal of Cancer 87 (2002) 129-133
4. Chen C.H., and Yang S.W. New steroid acids from Antrodia cinnamomea, a fungal parasite of cinnamomum micranthum. Journal of Natural Products 58 (1995) 1655-1661
5. Collins A., Yuan L., Kiefer T.L., Cheng Q., Lai L., and Hill S.M. Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice. Cancer Letters 89 (2003) 49-57
6. Elledge S.J., Richman R., Hall F.L., Williams R.T., Lodgson N., and Harper J.W. CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle. In: Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 2907-2911
7. Evan G.I., and Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 411 (2001) 342-348
8. Gavrieli Y., Sherman Y., and Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Journal of Cell Biology 119 (1992) 493-501
9. Guadagno T.M., and Newport J.W. CDK2 kinase is required for entry into mitosis as a positive regulator of CDC2-cyclin B kinase activity. Cell 84 (1996) 73-82
10. Hseu Y.C., Chang W.C., Hseu Y.T., Lee C.Y., Yech Y.J., Chen P.C., and Yang H.L. Protection of oxidative damage by water extract from Antrodia camphorata mycelia in normal human red blood cells. Life Sciences 71 (2002) 469-482
11. Hseu Y.C., Yang H.L., Lai Y.C., Lin J.G., Chen G.W., and Chang Y.H. Induction of apoptosis by Antrodia camphorata in human premyelocytic leukemia HL-60 cells. Nutrition and Cancer 48 (2004) 189-197
12. Hseu Y.C., Wu F.Y., Wu J.J., Chen J.Y., Chang W.H., Lu F.J., Lai Y.C., and Yang H.L. Anti-inflammatory potential of Antrodia camphorata through inhibition of iNOS, COX-2 and cytokines via the NF-kB pathway. International Immunopharmacology 5 (2005) 1914-1925
13. Hseu Y.C., Chen S.C., Tsai P.C., Chen C.S., Lu F.J., and Yang H.L. Inhibition of cyclooxygenase-2 and induction of apoptosis in estrogen-nonresponsive breast cancer cells by Antrodia camphorata. Food and Chemical Toxicology 45 (2007) 1107-1115
14. Hu H., Ahn N.S., Yang X., Lee Y.S., and Kang K.S. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. International Journal of Cancer 102 (2002) 250-253
15. Hu W., and Kavanagh J.J. Anticancer therapy targeting the apoptotic pathway. Lancet Oncology 4 (2003) 721-729
16. Jackson S.J., and Singletary K.W. Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. Journal of Nutrition 134 (2004) 2229-2236
17. Kiechle F.L., and Zhang X. Apoptosis: biochemical aspects and clinical implications. Clinica Chimica Acta 326 (2002) 27-45
18. Kim H.K., Park I.A., Heo D.S., Noh D.Y., Choe K.J., Bang Y.J., and Kim N.K. Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer. European Journal of Surgical Oncology 27 (2001) 464-471
19. Li X.K., Motwani M., Tong W., Bornmann W., Schwartz G.K., and Huanglian A. Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Molecular Pharmaceutics 58 (2000) 1287-1293
20. Lin W.C., Kuo S.C., and Wu Y.W. Effects of 28-day's repeated oral administration of the fermented extract of mycelia of Antrodia comphorata on rats. Journal of Chinese Medicine 12 (2001) 293-303
21. Nicholson D.W. From bench to clinic with apoptosis-based therapeutic agents. Nature 407 (2000) 810-816
22. Nigg E.A. Targets of cyclin-dependent protein kinases. Current Opinion in Cell Biology 5 (1993) 187-193
23. Paunesku T., Mittal S., Protic M., Oryhon J., Korolev S.V., Joachimiak A., and Woloschak G.E. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. International Journal of Radiation Biology 77 (2001) 1007-1021
24. Pozo-Guisado E., Alvarez-Barrientos A., Mulero-Navarro S., Santiago-Josefat B., and Fernandez-Salguero P.M. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochemical Pharmacology 64 (2002) 1375-1386
25. Rosenblatt J., Gu Y., and Morgan D.O. Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 2824-2828
26. Sandal T., Stapnes C., Kleivdal H., Hedin L., and Doskeland S.O. A novel, extraneuronal role for cyclin-dependent protein kinase 5 (CDK5): modulation of cAMP-induced apoptosis in rat leukemia cells. Journal of Biological Chemistry 277 (2002) 20783-20793
27. Sausville E.A., Johnson J., Alley M., Zaharevitz D., and Senderowicz A.M. Inhibition of CDKs as a therapeutic modality. Annals of the New York Academy of Sciences 910 (2000) 207-221
28. Schmitt C.A. Senescence, apoptosis and therapy - cutting the lifelines of cancer. Nature Reviews Cancer 3 (2003) 286-295
29. Schwartsmann G., Ratain M.J., Cragg G.M., Wong J.E., Saijo N., Parkinson D.R., Fujiwara Y., Pazdur R., Newman D.J., Dagher R., and Di Leone L. Anticancer drug discovery and development throughout the world. American Journal of Clinical Oncology 20 (2002) 47S-59S
30. Sherr C.J. G1 phase progression: cycling on cue. Cell 79 (1994) 551-555
31. Sherr C.J. Mammalian G1 cyclins and cell cycle progression. Proceedings of the Association of American Physicians 107 (1995) 181-186
32. Song T.Y., and Yen G.C. Antioxidant properties of Antrodia camphorata in submerged culture. Journal of Agricultural and Food Chemistry 50 (2002) 3322-3327
33. Sporn M.B., and Suh N. Chemoprevention of cancer. Carcinogenesis 21 (2000) 525-530
34. Sporn M.B., and Suh N. Chemoprevention: an essential approach to controlling cancer. Nature Reviews Cancer 2 (2002) 537-543
35. Stewart Z.A., Westfall M.D., and Pietenpol J.A. Cell-cycle dysregulation and anticancer therapy. Trends in Pharmacological Sciences 24 (2003) 139-145
36. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer 3 (2003) 768-780
37. Thangapazham R.L., Singh A.K., Sharma A., Warren J., Gaddipati J.P., and Maheshwari R.K. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Letters 245 (2007) 232-241
38. Tsai Z.T., and Liaw S.L. The use and the effect of Ganoderma (1985), San Yun Press, Taichung Taiwan pp. 116-117
39. Vickers A. Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Investigation 20 (2002) 1069-1079
40. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., and Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369 (1994) 669-671
41. Wu S.H., Ryvarden L., and Chang T.T. Antrodia cinnamomea (niu-chang-chih), New combination of a medicinal fungus in Taiwan. Botanical bulletin of Academia Sinica 38 (1997) 273-275
42. Yang H.L., Hseu Y.C., Chen J.Y., Yech Y.J., Lu F.J., Wang H.H., Lin P.S., and Wang B.C. Antrodia camphorata in submerged culture protects low density lipoproteins against oxidative modification. American Journal of Chinese Medicine 34 (2006) 217-231
43. Yang H.L., Chen C.S., Chang W.H., Lu F.J., Lai Y.C., Chen C.C., Hseu T.H., Kuo C.T., and Hseu Y.C. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata. Cancer Letters 231 (2006) 215-227
44. Zang M., and Su C.H. Ganoderma comphoratum, a new taxon in genus Ganoderma From Taiwan, China. Acta Botanical Yunnanical 12 (1990) 395-396